

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axonemal dynein complex assembly (GO:0070286) | 7.56762008 |
| 2 | ribosomal small subunit assembly (GO:0000028) | 6.60081502 |
| 3 | cilium or flagellum-dependent cell motility (GO:0001539) | 6.48775127 |
| 4 | viral transcription (GO:0019083) | 5.82567439 |
| 5 | translational termination (GO:0006415) | 5.50279828 |
| 6 | cilium movement (GO:0003341) | 5.49420141 |
| 7 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 5.43604151 |
| 8 | cotranslational protein targeting to membrane (GO:0006613) | 5.38714712 |
| 9 | protein targeting to ER (GO:0045047) | 5.34046169 |
| 10 | motile cilium assembly (GO:0044458) | 5.29988052 |
| 11 | ribosomal small subunit biogenesis (GO:0042274) | 5.13040201 |
| 12 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 5.06085633 |
| 13 | protein localization to endoplasmic reticulum (GO:0070972) | 5.04559320 |
| 14 | epithelial cilium movement (GO:0003351) | 5.04057114 |
| 15 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.84394556 |
| 16 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 4.66095939 |
| 17 | translational elongation (GO:0006414) | 4.64469561 |
| 18 | DNA deamination (GO:0045006) | 4.51514921 |
| 19 | positive regulation of tolerance induction (GO:0002645) | 4.47757430 |
| 20 | viral life cycle (GO:0019058) | 4.44141289 |
| 21 | cellular protein complex disassembly (GO:0043624) | 4.23955696 |
| 22 | left/right pattern formation (GO:0060972) | 4.09694196 |
| 23 | regulation of regulatory T cell differentiation (GO:0045589) | 4.05181166 |
| 24 | ribosomal large subunit biogenesis (GO:0042273) | 4.01626458 |
| 25 | regulation of tolerance induction (GO:0002643) | 3.97330912 |
| 26 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.92594783 |
| 27 | signal peptide processing (GO:0006465) | 3.80760245 |
| 28 | macrophage activation involved in immune response (GO:0002281) | 3.77647520 |
| 29 | translational initiation (GO:0006413) | 3.77187541 |
| 30 | translation (GO:0006412) | 3.73847939 |
| 31 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.70507547 |
| 32 | neutrophil activation (GO:0042119) | 3.68554647 |
| 33 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.67988513 |
| 34 | maturation of SSU-rRNA (GO:0030490) | 3.67408664 |
| 35 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.57660635 |
| 36 | protein complex disassembly (GO:0043241) | 3.55483738 |
| 37 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.50858631 |
| 38 | ATP synthesis coupled proton transport (GO:0015986) | 3.50858631 |
| 39 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.50136493 |
| 40 | axoneme assembly (GO:0035082) | 3.49943680 |
| 41 | GTP biosynthetic process (GO:0006183) | 3.49311234 |
| 42 | GPI anchor biosynthetic process (GO:0006506) | 3.49251118 |
| 43 | detection of other organism (GO:0098543) | 3.48977030 |
| 44 | detection of bacterium (GO:0016045) | 3.45143148 |
| 45 | granulocyte activation (GO:0036230) | 3.44561288 |
| 46 | respiratory chain complex IV assembly (GO:0008535) | 3.44189008 |
| 47 | protein targeting to membrane (GO:0006612) | 3.43492279 |
| 48 | T-helper 1 type immune response (GO:0042088) | 3.40533141 |
| 49 | macromolecular complex disassembly (GO:0032984) | 3.40448073 |
| 50 | negative regulation of interleukin-12 production (GO:0032695) | 3.35776592 |
| 51 | proteasome assembly (GO:0043248) | 3.33344194 |
| 52 | cytochrome complex assembly (GO:0017004) | 3.31331840 |
| 53 | negative regulation of interleukin-8 production (GO:0032717) | 3.27688647 |
| 54 | positive regulation by symbiont of host defense response (GO:0052509) | 3.21028075 |
| 55 | modulation by symbiont of host defense response (GO:0052031) | 3.21028075 |
| 56 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.21028075 |
| 57 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.21028075 |
| 58 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.21028075 |
| 59 | modulation by symbiont of host immune response (GO:0052553) | 3.21028075 |
| 60 | regulation of protein glycosylation (GO:0060049) | 3.20295784 |
| 61 | regulation of T cell tolerance induction (GO:0002664) | 3.18663910 |
| 62 | respiratory electron transport chain (GO:0022904) | 3.18506001 |
| 63 | activated T cell proliferation (GO:0050798) | 3.16239829 |
| 64 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.15919115 |
| 65 | termination of RNA polymerase III transcription (GO:0006386) | 3.15919115 |
| 66 | purine nucleotide salvage (GO:0032261) | 3.14160729 |
| 67 | electron transport chain (GO:0022900) | 3.13529691 |
| 68 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.11517074 |
| 69 | response to peptidoglycan (GO:0032494) | 3.09509228 |
| 70 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.08656558 |
| 71 | protein complex biogenesis (GO:0070271) | 3.07311577 |
| 72 | CTP biosynthetic process (GO:0006241) | 3.06898375 |
| 73 | CTP metabolic process (GO:0046036) | 3.06898375 |
| 74 | positive regulation of mast cell activation (GO:0033005) | 3.04180867 |
| 75 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.01994682 |
| 76 | neutrophil chemotaxis (GO:0030593) | 2.99746388 |
| 77 | regulation of cilium movement (GO:0003352) | 2.98382735 |
| 78 | viral protein processing (GO:0019082) | 2.96165711 |
| 79 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.95342144 |
| 80 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.94313009 |
| 81 | detection of external biotic stimulus (GO:0098581) | 2.94254294 |
| 82 | UTP biosynthetic process (GO:0006228) | 2.92717086 |
| 83 | detection of molecule of bacterial origin (GO:0032490) | 2.92266722 |
| 84 | GDP-mannose metabolic process (GO:0019673) | 2.92079817 |
| 85 | neutrophil migration (GO:1990266) | 2.91956681 |
| 86 | modulation by symbiont of host cellular process (GO:0044068) | 2.91531365 |
| 87 | macrophage activation (GO:0042116) | 2.89750150 |
| 88 | modulation by virus of host process (GO:0019054) | 2.89711720 |
| 89 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.88028925 |
| 90 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.87564359 |
| 91 | mannosylation (GO:0097502) | 2.87369205 |
| 92 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.87052263 |
| 93 | neutrophil activation involved in immune response (GO:0002283) | 2.86684228 |
| 94 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.86009065 |
| 95 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.85166204 |
| 96 | iron-sulfur cluster assembly (GO:0016226) | 2.83184524 |
| 97 | metallo-sulfur cluster assembly (GO:0031163) | 2.83184524 |
| 98 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.83152842 |
| 99 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.82024817 |
| 100 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.81031124 |
| 101 | response to magnesium ion (GO:0032026) | 2.80874745 |
| 102 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.80526815 |
| 103 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.80496075 |
| 104 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.79287199 |
| 105 | positive regulation of mast cell degranulation (GO:0043306) | 2.79287199 |
| 106 | mRNA catabolic process (GO:0006402) | 2.78624801 |
| 107 | GPI anchor metabolic process (GO:0006505) | 2.78083781 |
| 108 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.78081949 |
| 109 | ncRNA 3-end processing (GO:0043628) | 2.77357391 |
| 110 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.76305214 |
| 111 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.76305214 |
| 112 | NADH dehydrogenase complex assembly (GO:0010257) | 2.76305214 |
| 113 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.76100385 |
| 114 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.72882268 |
| 115 | sequestering of actin monomers (GO:0042989) | 2.72647826 |
| 116 | cellular response to type I interferon (GO:0071357) | 2.71852349 |
| 117 | type I interferon signaling pathway (GO:0060337) | 2.71852349 |
| 118 | tolerance induction (GO:0002507) | 2.71438497 |
| 119 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.70757516 |
| 120 | response to type I interferon (GO:0034340) | 2.70002932 |
| 121 | granulocyte chemotaxis (GO:0071621) | 2.69974819 |
| 122 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.69198300 |
| 123 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 2.68223524 |
| 124 | mannose metabolic process (GO:0006013) | 2.66264273 |
| 125 | peptidyl-histidine modification (GO:0018202) | 2.66182198 |
| 126 | ubiquinone biosynthetic process (GO:0006744) | 2.64383795 |
| 127 | superoxide anion generation (GO:0042554) | 2.61857591 |
| 128 | response to interferon-beta (GO:0035456) | 2.61585834 |
| 129 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.60974654 |
| 130 | immunoglobulin mediated immune response (GO:0016064) | 2.60500826 |
| 131 | UTP metabolic process (GO:0046051) | 2.60416435 |
| 132 | regulation of cholesterol storage (GO:0010885) | 2.60104266 |
| 133 | detection of biotic stimulus (GO:0009595) | 2.59647108 |
| 134 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.58253036 |
| 135 | regulation of mitochondrial translation (GO:0070129) | 2.58054548 |
| 136 | granulocyte migration (GO:0097530) | 2.57805177 |
| 137 | response to xenobiotic stimulus (GO:0009410) | 2.56087360 |
| 138 | negative regulation of B cell mediated immunity (GO:0002713) | 2.55877351 |
| 139 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.55877351 |
| 140 | regulation of germinal center formation (GO:0002634) | 2.55730217 |
| 141 | nucleoside diphosphate catabolic process (GO:0009134) | 2.53148083 |
| 142 | cellular response to interferon-beta (GO:0035458) | 2.52248320 |
| 143 | RNA catabolic process (GO:0006401) | 2.52215914 |
| 144 | response to manganese ion (GO:0010042) | 2.51830950 |
| 145 | regulation of superoxide anion generation (GO:0032928) | 2.51320454 |
| 146 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.47905946 |
| 147 | establishment of protein localization to membrane (GO:0090150) | 2.47271982 |
| 148 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.47141729 |
| 149 | adaptation of signaling pathway (GO:0023058) | 2.46951843 |
| 150 | intraciliary transport (GO:0042073) | 2.46517974 |
| 151 | pyrimidine ribonucleoside triphosphate metabolic process (GO:0009208) | 2.45528883 |
| 152 | mitochondrion degradation (GO:0000422) | 2.45381955 |
| 153 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.45321079 |
| 154 | negative regulation of interleukin-6 production (GO:0032715) | 2.45264709 |
| 155 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.44423262 |
| 156 | amyloid precursor protein catabolic process (GO:0042987) | 2.44394358 |
| 157 | regulation of metalloenzyme activity (GO:0048552) | 2.44247130 |
| 158 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.44192414 |
| 159 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.43363227 |
| 160 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 2.42734467 |
| 161 | C-terminal protein lipidation (GO:0006501) | 2.42284251 |
| 162 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.42018336 |
| 163 | myeloid cell activation involved in immune response (GO:0002275) | 2.40661477 |
| 164 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.39892297 |
| 165 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.38522012 |
| 166 | microglial cell activation (GO:0001774) | 2.38133788 |
| 167 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.38064093 |
| 168 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.36936587 |
| 169 | regulation of mast cell degranulation (GO:0043304) | 2.36877345 |
| 170 | G-protein coupled receptor internalization (GO:0002031) | 2.36748061 |
| 171 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.35797224 |
| 172 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.35651839 |
| 173 | deoxyribonucleotide catabolic process (GO:0009264) | 2.35119257 |
| 174 | dendritic cell chemotaxis (GO:0002407) | 2.34959532 |
| 175 | platelet dense granule organization (GO:0060155) | 2.34903569 |
| 176 | positive regulation of antigen processing and presentation (GO:0002579) | 2.34010734 |
| 177 | polyamine metabolic process (GO:0006595) | 2.33939110 |
| 178 | diol metabolic process (GO:0034311) | 2.33058910 |
| 179 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.32843404 |
| 180 | regulation of antigen processing and presentation (GO:0002577) | 2.32364743 |
| 181 | cellular component biogenesis (GO:0044085) | 2.31929763 |
| 182 | heme biosynthetic process (GO:0006783) | 2.31814654 |
| 183 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.31634628 |
| 184 | NIK/NF-kappaB signaling (GO:0038061) | 2.31570164 |
| 185 | regulation of respiratory burst (GO:0060263) | 2.31176306 |
| 186 | diacylglycerol metabolic process (GO:0046339) | 2.31140512 |
| 187 | protein targeting (GO:0006605) | 2.31013950 |
| 188 | hypotonic response (GO:0006971) | 2.30968961 |
| 189 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.30648453 |
| 190 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.29876713 |
| 191 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.29876713 |
| 192 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.29876713 |
| 193 | 7-methylguanosine mRNA capping (GO:0006370) | 2.29860630 |
| 194 | leukocyte aggregation (GO:0070486) | 2.29598885 |
| 195 | protein insertion into membrane (GO:0051205) | 2.29310260 |
| 196 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.28656756 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 5.96156026 |
| 2 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.76847741 |
| 3 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.79624264 |
| 4 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.69878132 |
| 5 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.66585607 |
| 6 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.55861794 |
| 7 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.30591833 |
| 8 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.30364728 |
| 9 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.29040795 |
| 10 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.19556229 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.97172507 |
| 12 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.93968724 |
| 13 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.91560947 |
| 14 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.80476308 |
| 15 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.78780863 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.73477764 |
| 17 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.64947058 |
| 18 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.58890352 |
| 19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.58163448 |
| 20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.57710918 |
| 21 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.56208906 |
| 22 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.50530239 |
| 23 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.47884704 |
| 24 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.39295625 |
| 25 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.31903816 |
| 26 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.29698309 |
| 27 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.28569296 |
| 28 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.25085458 |
| 29 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.23024974 |
| 30 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.23001695 |
| 31 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.21758222 |
| 32 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.20829240 |
| 33 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 2.19834599 |
| 34 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.09802373 |
| 35 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.09010187 |
| 36 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 2.06370962 |
| 37 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.03284887 |
| 38 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.01521269 |
| 39 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.98845806 |
| 40 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.98637741 |
| 41 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.97461311 |
| 42 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.95151504 |
| 43 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.94146723 |
| 44 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.93867867 |
| 45 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.93104526 |
| 46 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.88020670 |
| 47 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.86421574 |
| 48 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.84338218 |
| 49 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.82699751 |
| 50 | P68_20966046_ChIP-Seq_HELA_Human | 1.79692219 |
| 51 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.79395599 |
| 52 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.75395703 |
| 53 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75280246 |
| 54 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.74817162 |
| 55 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.73923202 |
| 56 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.71887069 |
| 57 | SPI1_23127762_ChIP-Seq_K562_Human | 1.67828161 |
| 58 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.66943911 |
| 59 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.66657814 |
| 60 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66561094 |
| 61 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65404580 |
| 62 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.62842773 |
| 63 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.62521458 |
| 64 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.59617165 |
| 65 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.59177224 |
| 66 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.58265200 |
| 67 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.57734658 |
| 68 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.57228025 |
| 69 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.55018190 |
| 70 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.52540655 |
| 71 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.52213354 |
| 72 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.51154700 |
| 73 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.48353437 |
| 74 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.47390214 |
| 75 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.47388475 |
| 76 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.43357249 |
| 77 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.42802075 |
| 78 | P300_27268052_Chip-Seq_Bcells_Human | 1.41164665 |
| 79 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.40866230 |
| 80 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.40762816 |
| 81 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.39601145 |
| 82 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.38828956 |
| 83 | SA1_27219007_Chip-Seq_Bcells_Human | 1.38203830 |
| 84 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37811738 |
| 85 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.37066538 |
| 86 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.36028560 |
| 87 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.34835182 |
| 88 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.30440367 |
| 89 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.30379337 |
| 90 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.29728145 |
| 91 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.29284961 |
| 92 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.27583106 |
| 93 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.26082967 |
| 94 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.23358447 |
| 95 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.23322177 |
| 96 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.22687663 |
| 97 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.21688173 |
| 98 | MYB_26560356_Chip-Seq_TH2_Human | 1.21131550 |
| 99 | MAF_26560356_Chip-Seq_TH1_Human | 1.20596776 |
| 100 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.20596632 |
| 101 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.19288789 |
| 102 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.18902895 |
| 103 | UTX_26944678_Chip-Seq_JUKART_Human | 1.18297683 |
| 104 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.18291597 |
| 105 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.18103073 |
| 106 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.17628116 |
| 107 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.17488431 |
| 108 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.17482139 |
| 109 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.17470369 |
| 110 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.16921045 |
| 111 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.15760785 |
| 112 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.15752683 |
| 113 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.15732319 |
| 114 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.15696952 |
| 115 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.14655255 |
| 116 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.14288515 |
| 117 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13657079 |
| 118 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.13367852 |
| 119 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.13279378 |
| 120 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.13009512 |
| 121 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.12179162 |
| 122 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.10035740 |
| 123 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.08529968 |
| 124 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.08309532 |
| 125 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.07850720 |
| 126 | MAF_26560356_Chip-Seq_TH2_Human | 1.07366132 |
| 127 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.07137146 |
| 128 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.06971900 |
| 129 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.06867738 |
| 130 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.06401992 |
| 131 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.06200846 |
| 132 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.05953910 |
| 133 | GATA1_19941826_ChIP-Seq_K562_Human | 1.04708767 |
| 134 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.04403013 |
| 135 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.03867257 |
| 136 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01825972 |
| 137 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.01748813 |
| 138 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.00409547 |
| 139 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.00304817 |
| 140 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.99701764 |
| 141 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.98793282 |
| 142 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.97954869 |
| 143 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96886840 |
| 144 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.96595786 |
| 145 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.96315748 |
| 146 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.95253615 |
| 147 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.95203867 |
| 148 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.94661270 |
| 149 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.94657686 |
| 150 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.94645361 |
| 151 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.94366583 |
| 152 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.94175333 |
| 153 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94149863 |
| 154 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.93508625 |
| 155 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.93211211 |
| 156 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.93196302 |
| 157 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.92763006 |
| 158 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.92539117 |
| 159 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.92489605 |
| 160 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91487094 |
| 161 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.90973777 |
| 162 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.90425803 |
| 163 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89916187 |
| 164 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89428644 |
| 165 | GATA1_22025678_ChIP-Seq_K562_Human | 0.88899074 |
| 166 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88686853 |
| 167 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.88221214 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008260_abnormal_autophagy | 3.49126086 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.42593623 |
| 3 | MP0009379_abnormal_foot_pigmentation | 3.38765733 |
| 4 | MP0005671_abnormal_response_to | 3.05695310 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 2.97562003 |
| 6 | MP0009785_altered_susceptibility_to | 2.89786175 |
| 7 | MP0003303_peritoneal_inflammation | 2.73218378 |
| 8 | MP0003724_increased_susceptibility_to | 2.61297716 |
| 9 | MP0003763_abnormal_thymus_physiology | 2.55861669 |
| 10 | MP0002653_abnormal_ependyma_morphology | 2.52202842 |
| 11 | MP0003183_abnormal_peptide_metabolism | 2.36663514 |
| 12 | MP0001873_stomach_inflammation | 2.35731276 |
| 13 | MP0005025_abnormal_response_to | 2.34904606 |
| 14 | MP0005000_abnormal_immune_tolerance | 2.33322730 |
| 15 | MP0009333_abnormal_splenocyte_physiolog | 2.27912103 |
| 16 | MP0000685_abnormal_immune_system | 2.26243380 |
| 17 | MP0001790_abnormal_immune_system | 2.23317525 |
| 18 | MP0005387_immune_system_phenotype | 2.23317525 |
| 19 | MP0005409_darkened_coat_color | 2.17323749 |
| 20 | MP0002723_abnormal_immune_serum | 2.07808689 |
| 21 | MP0001800_abnormal_humoral_immune | 2.07484274 |
| 22 | MP0002420_abnormal_adaptive_immunity | 2.05891414 |
| 23 | MP0002452_abnormal_antigen_presenting | 2.04201625 |
| 24 | MP0001819_abnormal_immune_cell | 2.03539832 |
| 25 | MP0002419_abnormal_innate_immunity | 2.00398712 |
| 26 | MP0003693_abnormal_embryo_hatching | 1.97713011 |
| 27 | MP0003191_abnormal_cellular_cholesterol | 1.92901442 |
| 28 | MP0003186_abnormal_redox_activity | 1.90827338 |
| 29 | MP0009278_abnormal_bone_marrow | 1.85793166 |
| 30 | MP0002132_abnormal_respiratory_system | 1.83367597 |
| 31 | MP0005075_abnormal_melanosome_morpholog | 1.82887282 |
| 32 | MP0002396_abnormal_hematopoietic_system | 1.82774551 |
| 33 | MP0005174_abnormal_tail_pigmentation | 1.80772517 |
| 34 | MP0002166_altered_tumor_susceptibility | 1.80550006 |
| 35 | MP0010155_abnormal_intestine_physiology | 1.76383819 |
| 36 | MP0000490_abnormal_crypts_of | 1.76159931 |
| 37 | MP0003075_altered_response_to | 1.75699272 |
| 38 | MP0001986_abnormal_taste_sensitivity | 1.74543305 |
| 39 | MP0003436_decreased_susceptibility_to | 1.73529021 |
| 40 | MP0004381_abnormal_hair_follicle | 1.72128141 |
| 41 | MP0004147_increased_porphyrin_level | 1.71440178 |
| 42 | MP0005670_abnormal_white_adipose | 1.71352648 |
| 43 | MP0002405_respiratory_system_inflammati | 1.69255047 |
| 44 | MP0008004_abnormal_stomach_pH | 1.68188601 |
| 45 | MP0003866_abnormal_defecation | 1.66244614 |
| 46 | MP0002398_abnormal_bone_marrow | 1.61123481 |
| 47 | MP0005310_abnormal_salivary_gland | 1.59956135 |
| 48 | MP0000716_abnormal_immune_system | 1.58973622 |
| 49 | MP0005083_abnormal_biliary_tract | 1.54081004 |
| 50 | MP0000566_synostosis | 1.52082347 |
| 51 | MP0002006_tumorigenesis | 1.47561880 |
| 52 | MP0005503_abnormal_tendon_morphology | 1.45954186 |
| 53 | MP0003172_abnormal_lysosome_physiology | 1.45079257 |
| 54 | MP0000015_abnormal_ear_pigmentation | 1.44508961 |
| 55 | MP0000372_irregular_coat_pigmentation | 1.44337284 |
| 56 | MP0001845_abnormal_inflammatory_respons | 1.43830603 |
| 57 | MP0001188_hyperpigmentation | 1.41604189 |
| 58 | MP0002429_abnormal_blood_cell | 1.38328269 |
| 59 | MP0002722_abnormal_immune_system | 1.38280980 |
| 60 | MP0002277_abnormal_respiratory_mucosa | 1.33850418 |
| 61 | MP0006082_CNS_inflammation | 1.32183921 |
| 62 | MP0000858_altered_metastatic_potential | 1.31985720 |
| 63 | MP0002095_abnormal_skin_pigmentation | 1.31287629 |
| 64 | MP0000689_abnormal_spleen_morphology | 1.30919303 |
| 65 | MP0000613_abnormal_salivary_gland | 1.30676949 |
| 66 | MP0001663_abnormal_digestive_system | 1.29186927 |
| 67 | MP0002822_catalepsy | 1.28954701 |
| 68 | MP0000013_abnormal_adipose_tissue | 1.28107407 |
| 69 | MP0002933_joint_inflammation | 1.26405114 |
| 70 | MP0001853_heart_inflammation | 1.26273158 |
| 71 | MP0005058_abnormal_lysosome_morphology | 1.25547630 |
| 72 | MP0008875_abnormal_xenobiotic_pharmacok | 1.24145167 |
| 73 | MP0002163_abnormal_gland_morphology | 1.23739270 |
| 74 | MP0000703_abnormal_thymus_morphology | 1.19599801 |
| 75 | MP0003806_abnormal_nucleotide_metabolis | 1.17083211 |
| 76 | MP0005464_abnormal_platelet_physiology | 1.16851680 |
| 77 | MP0008469_abnormal_protein_level | 1.16376693 |
| 78 | MP0000465_gastrointestinal_hemorrhage | 1.15155603 |
| 79 | MP0004133_heterotaxia | 1.14719397 |
| 80 | MP0000678_abnormal_parathyroid_gland | 1.13746691 |
| 81 | MP0003279_aneurysm | 1.11274035 |
| 82 | MP0002638_abnormal_pupillary_reflex | 1.11175411 |
| 83 | MP0003656_abnormal_erythrocyte_physiolo | 1.09870420 |
| 84 | MP0000920_abnormal_myelination | 1.07961322 |
| 85 | MP0009765_abnormal_xenobiotic_induced | 1.07271928 |
| 86 | MP0005023_abnormal_wound_healing | 1.06603752 |
| 87 | MP0003136_yellow_coat_color | 1.05376620 |
| 88 | MP0006035_abnormal_mitochondrial_morpho | 1.05344303 |
| 89 | MP0005220_abnormal_exocrine_pancreas | 1.03878451 |
| 90 | MP0005397_hematopoietic_system_phenotyp | 1.03711690 |
| 91 | MP0001545_abnormal_hematopoietic_system | 1.03711690 |
| 92 | MP0008058_abnormal_DNA_repair | 1.03659634 |
| 93 | MP0005595_abnormal_vascular_smooth | 1.03273378 |
| 94 | MP0002735_abnormal_chemical_nociception | 1.02710832 |
| 95 | MP0005636_abnormal_mineral_homeostasis | 1.01922114 |
| 96 | MP0008789_abnormal_olfactory_epithelium | 1.01310780 |
| 97 | MP0005379_endocrine/exocrine_gland_phen | 1.01059833 |
| 98 | MP0009764_decreased_sensitivity_to | 1.00700485 |
| 99 | MP0001533_abnormal_skeleton_physiology | 1.00174777 |
| 100 | MP0004947_skin_inflammation | 0.99606060 |
| 101 | MP0005408_hypopigmentation | 0.98308284 |
| 102 | MP0000358_abnormal_cell_content/ | 0.98097794 |
| 103 | MP0005381_digestive/alimentary_phenotyp | 0.97564752 |
| 104 | MP0000750_abnormal_muscle_regeneration | 0.96780828 |
| 105 | MP0002928_abnormal_bile_duct | 0.96573242 |
| 106 | MP0009763_increased_sensitivity_to | 0.91331406 |
| 107 | MP0005197_abnormal_uvea_morphology | 0.91216706 |
| 108 | MP0002938_white_spotting | 0.91207268 |
| 109 | MP0005084_abnormal_gallbladder_morpholo | 0.90772576 |
| 110 | MP0005390_skeleton_phenotype | 0.87848423 |
| 111 | MP0004510_myositis | 0.87666627 |
| 112 | MP0004019_abnormal_vitamin_homeostasis | 0.87550794 |
| 113 | MP0001764_abnormal_homeostasis | 0.87539257 |
| 114 | MP0000343_altered_response_to | 0.87252188 |
| 115 | MP0002282_abnormal_trachea_morphology | 0.86740304 |
| 116 | MP0005451_abnormal_body_composition | 0.86129800 |
| 117 | MP0005164_abnormal_response_to | 0.85684050 |
| 118 | MP0001905_abnormal_dopamine_level | 0.85456257 |
| 119 | MP0001346_abnormal_lacrimal_gland | 0.85309760 |
| 120 | MP0001851_eye_inflammation | 0.84403337 |
| 121 | MP0003941_abnormal_skin_development | 0.83767997 |
| 122 | MP0005166_decreased_susceptibility_to | 0.83323909 |
| 123 | MP0005165_increased_susceptibility_to | 0.82744591 |
| 124 | MP0002098_abnormal_vibrissa_morphology | 0.82116523 |
| 125 | MP0003705_abnormal_hypodermis_morpholog | 0.81970157 |
| 126 | MP0004043_abnormal_pH_regulation | 0.81857394 |
| 127 | MP0001529_abnormal_vocalization | 0.81836775 |
| 128 | MP0001849_ear_inflammation | 0.81828021 |
| 129 | MP0001542_abnormal_bone_strength | 0.81250839 |
| 130 | MP0000371_diluted_coat_color | 0.80164994 |
| 131 | MP0010386_abnormal_urinary_bladder | 0.79684279 |
| 132 | MP0002138_abnormal_hepatobiliary_system | 0.79582826 |
| 133 | MP0000470_abnormal_stomach_morphology | 0.79392474 |
| 134 | MP0008932_abnormal_embryonic_tissue | 0.78529388 |
| 135 | MP0003878_abnormal_ear_physiology | 0.78263719 |
| 136 | MP0005377_hearing/vestibular/ear_phenot | 0.78263719 |
| 137 | MP0006036_abnormal_mitochondrial_physio | 0.77621804 |
| 138 | MP0002136_abnormal_kidney_physiology | 0.75818005 |
| 139 | MP0003453_abnormal_keratinocyte_physiol | 0.75046134 |
| 140 | MP0005501_abnormal_skin_physiology | 0.74841289 |
| 141 | MP0009384_cardiac_valve_regurgitation | 0.74107972 |
| 142 | MP0002693_abnormal_pancreas_physiology | 0.73121389 |
| 143 | MP0003448_altered_tumor_morphology | 0.72849888 |
| 144 | MP0003300_gastrointestinal_ulcer | 0.72693081 |
| 145 | MP0000604_amyloidosis | 0.71802771 |
| 146 | MP0009643_abnormal_urine_homeostasis | 0.71236700 |
| 147 | MP0000681_abnormal_thyroid_gland | 0.71219431 |
| 148 | MP0001664_abnormal_digestion | 0.70182236 |
| 149 | MP0000049_abnormal_middle_ear | 0.70158148 |
| 150 | MP0005645_abnormal_hypothalamus_physiol | 0.70055618 |
| 151 | MP0003795_abnormal_bone_structure | 0.69610345 |
| 152 | MP0008007_abnormal_cellular_replicative | 0.68198476 |
| 153 | MP0005367_renal/urinary_system_phenotyp | 0.67231467 |
| 154 | MP0000516_abnormal_urinary_system | 0.67231467 |
| 155 | MP0002115_abnormal_skeleton_extremities | 0.65480199 |
| 156 | MP0002249_abnormal_larynx_morphology | 0.65460831 |
| 157 | MP0003633_abnormal_nervous_system | 0.65237790 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 8.01977542 |
| 2 | Abnormal respiratory motile cilium physiology (HP:0012261) | 6.74330364 |
| 3 | Abnormal respiratory motile cilium morphology (HP:0005938) | 6.57705237 |
| 4 | Abnormal respiratory epithelium morphology (HP:0012253) | 6.57705237 |
| 5 | Absent/shortened dynein arms (HP:0200106) | 6.42355706 |
| 6 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 6.42355706 |
| 7 | Rhinitis (HP:0012384) | 6.24595304 |
| 8 | Recurrent gram-negative bacterial infections (HP:0005420) | 6.10020788 |
| 9 | Abnormal ciliary motility (HP:0012262) | 6.03785813 |
| 10 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.73665878 |
| 11 | Abnormal number of erythroid precursors (HP:0012131) | 4.52493410 |
| 12 | Reticulocytopenia (HP:0001896) | 4.48006222 |
| 13 | Chronic bronchitis (HP:0004469) | 4.42763148 |
| 14 | Nasal polyposis (HP:0100582) | 4.01941821 |
| 15 | Bronchiectasis (HP:0002110) | 3.98828024 |
| 16 | Acute necrotizing encephalopathy (HP:0006965) | 3.89692829 |
| 17 | Mitochondrial inheritance (HP:0001427) | 3.87249247 |
| 18 | Abnormality of glycolipid metabolism (HP:0010969) | 3.74980996 |
| 19 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.74980996 |
| 20 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.74980996 |
| 21 | Hepatocellular necrosis (HP:0001404) | 3.64847696 |
| 22 | Vacuolated lymphocytes (HP:0001922) | 3.62927183 |
| 23 | Abnormality of the nasal mucosa (HP:0000433) | 3.56737685 |
| 24 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.41760250 |
| 25 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 3.38039017 |
| 26 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.34058566 |
| 27 | Macrocytic anemia (HP:0001972) | 3.31111842 |
| 28 | Hepatic necrosis (HP:0002605) | 3.25367876 |
| 29 | Recurrent abscess formation (HP:0002722) | 3.23896817 |
| 30 | Renal Fanconi syndrome (HP:0001994) | 3.20048057 |
| 31 | Chronic sinusitis (HP:0011109) | 3.19824502 |
| 32 | Pallor (HP:0000980) | 3.19015588 |
| 33 | Type I transferrin isoform profile (HP:0003642) | 3.18606289 |
| 34 | Increased hepatocellular lipid droplets (HP:0006565) | 3.18393030 |
| 35 | Recurrent sinusitis (HP:0011108) | 3.13648533 |
| 36 | Petechiae (HP:0000967) | 3.11544973 |
| 37 | Increased CSF lactate (HP:0002490) | 3.10222440 |
| 38 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.06929737 |
| 39 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.06929737 |
| 40 | 3-Methylglutaconic aciduria (HP:0003535) | 3.05572983 |
| 41 | Gingivitis (HP:0000230) | 3.04773345 |
| 42 | Acute encephalopathy (HP:0006846) | 3.04204002 |
| 43 | Progressive macrocephaly (HP:0004481) | 3.02428103 |
| 44 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.98268482 |
| 45 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.97648474 |
| 46 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.93862566 |
| 47 | Recurrent bacterial skin infections (HP:0005406) | 2.75935586 |
| 48 | Recurrent otitis media (HP:0000403) | 2.75692768 |
| 49 | Parakeratosis (HP:0001036) | 2.75082110 |
| 50 | Lipid accumulation in hepatocytes (HP:0006561) | 2.74976703 |
| 51 | Exertional dyspnea (HP:0002875) | 2.70914758 |
| 52 | Aplastic anemia (HP:0001915) | 2.68871379 |
| 53 | IgM deficiency (HP:0002850) | 2.61092035 |
| 54 | Increased intramyocellular lipid droplets (HP:0012240) | 2.56583403 |
| 55 | Abnormal glycosylation (HP:0012345) | 2.54504965 |
| 56 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.54504965 |
| 57 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.54504965 |
| 58 | Abnormal protein glycosylation (HP:0012346) | 2.54504965 |
| 59 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.53394163 |
| 60 | Increased serum lactate (HP:0002151) | 2.50594287 |
| 61 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.49353174 |
| 62 | Bronchitis (HP:0012387) | 2.48843631 |
| 63 | Atelectasis (HP:0100750) | 2.40887530 |
| 64 | Eczematoid dermatitis (HP:0000976) | 2.39108174 |
| 65 | Periodontitis (HP:0000704) | 2.36758508 |
| 66 | Reduced antithrombin III activity (HP:0001976) | 2.35626655 |
| 67 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.34934633 |
| 68 | Thrombocytosis (HP:0001894) | 2.33843865 |
| 69 | Abnormality of renal resorption (HP:0011038) | 2.32397588 |
| 70 | Dysostosis multiplex (HP:0000943) | 2.30230180 |
| 71 | Chronic otitis media (HP:0000389) | 2.29944595 |
| 72 | Exercise intolerance (HP:0003546) | 2.29454896 |
| 73 | Microvesicular hepatic steatosis (HP:0001414) | 2.28942263 |
| 74 | Obstructive lung disease (HP:0006536) | 2.26310523 |
| 75 | Chronic obstructive pulmonary disease (HP:0006510) | 2.26310523 |
| 76 | Respiratory failure (HP:0002878) | 2.21334917 |
| 77 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.20950711 |
| 78 | Increased muscle lipid content (HP:0009058) | 2.20475510 |
| 79 | Increased cerebral lipofuscin (HP:0011813) | 2.20283838 |
| 80 | Abnormality of macrophages (HP:0004311) | 2.20111780 |
| 81 | Purpura (HP:0000979) | 2.18974745 |
| 82 | Duplicated collecting system (HP:0000081) | 2.18234697 |
| 83 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 2.17065000 |
| 84 | Severe visual impairment (HP:0001141) | 2.14650275 |
| 85 | Stridor (HP:0010307) | 2.13141512 |
| 86 | Hypoplasia of the uterus (HP:0000013) | 2.13082352 |
| 87 | Infertility (HP:0000789) | 2.09315531 |
| 88 | Recurrent skin infections (HP:0001581) | 2.08428785 |
| 89 | Pancytopenia (HP:0001876) | 2.08145122 |
| 90 | Abnormality of lateral ventricle (HP:0030047) | 2.06438052 |
| 91 | Cupped ribs (HP:0000887) | 2.05557176 |
| 92 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.04865978 |
| 93 | True hermaphroditism (HP:0010459) | 2.04263074 |
| 94 | Optic disc pallor (HP:0000543) | 2.02514008 |
| 95 | Short femoral neck (HP:0100864) | 2.01717924 |
| 96 | Systemic lupus erythematosus (HP:0002725) | 2.01307486 |
| 97 | Leukocytosis (HP:0001974) | 2.00994530 |
| 98 | Loss of speech (HP:0002371) | 2.00796536 |
| 99 | Lactic acidosis (HP:0003128) | 2.00677877 |
| 100 | Amyloidosis (HP:0011034) | 1.98689164 |
| 101 | Abnormality of the intervertebral disk (HP:0005108) | 1.98204735 |
| 102 | Pustule (HP:0200039) | 1.97968079 |
| 103 | Prolonged bleeding time (HP:0003010) | 1.97781329 |
| 104 | T lymphocytopenia (HP:0005403) | 1.97642038 |
| 105 | Congenital sensorineural hearing impairment (HP:0008527) | 1.96294055 |
| 106 | Abnormality of T cell number (HP:0011839) | 1.95841845 |
| 107 | Interstitial pulmonary disease (HP:0006530) | 1.95744775 |
| 108 | Occipital encephalocele (HP:0002085) | 1.95732493 |
| 109 | Autoimmune thrombocytopenia (HP:0001973) | 1.94706412 |
| 110 | Meningitis (HP:0001287) | 1.94664109 |
| 111 | Agammaglobulinemia (HP:0004432) | 1.94375877 |
| 112 | Panhypogammaglobulinemia (HP:0003139) | 1.94245335 |
| 113 | Patchy hypopigmentation of hair (HP:0011365) | 1.93543448 |
| 114 | Respiratory difficulties (HP:0002880) | 1.92211521 |
| 115 | Hypothermia (HP:0002045) | 1.92073223 |
| 116 | Anencephaly (HP:0002323) | 1.91696278 |
| 117 | Abnormality of the renal collecting system (HP:0004742) | 1.90092729 |
| 118 | Male infertility (HP:0003251) | 1.90081393 |
| 119 | Short nail (HP:0001799) | 1.90051945 |
| 120 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.87513118 |
| 121 | Asplenia (HP:0001746) | 1.87471267 |
| 122 | Recurrent viral infections (HP:0004429) | 1.86641824 |
| 123 | Abnormality of T cells (HP:0002843) | 1.85865789 |
| 124 | Abnormal hemoglobin (HP:0011902) | 1.85635005 |
| 125 | Dry hair (HP:0011359) | 1.85551400 |
| 126 | Recurrent pneumonia (HP:0006532) | 1.85454234 |
| 127 | Absent hand (HP:0004050) | 1.85332271 |
| 128 | Single umbilical artery (HP:0001195) | 1.84431518 |
| 129 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.84431518 |
| 130 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.84431518 |
| 131 | Chronic hepatic failure (HP:0100626) | 1.84256963 |
| 132 | Poor head control (HP:0002421) | 1.84149556 |
| 133 | Severe combined immunodeficiency (HP:0004430) | 1.83460325 |
| 134 | Leukodystrophy (HP:0002415) | 1.82884268 |
| 135 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.82839569 |
| 136 | Hepatosplenomegaly (HP:0001433) | 1.82568537 |
| 137 | Myositis (HP:0100614) | 1.82507760 |
| 138 | IgG deficiency (HP:0004315) | 1.80406384 |
| 139 | Hypergammaglobulinemia (HP:0010702) | 1.80036761 |
| 140 | White forelock (HP:0002211) | 1.79789384 |
| 141 | Hypoproteinemia (HP:0003075) | 1.79607778 |
| 142 | Abnormality of T cell physiology (HP:0011840) | 1.79302541 |
| 143 | Neutropenia (HP:0001875) | 1.78742160 |
| 144 | Recurrent fungal infections (HP:0002841) | 1.78266360 |
| 145 | Constricted visual fields (HP:0001133) | 1.77947373 |
| 146 | Abnormal vertebral ossification (HP:0100569) | 1.77433717 |
| 147 | Abnormality of B cell number (HP:0010975) | 1.77004815 |
| 148 | B lymphocytopenia (HP:0010976) | 1.77004815 |
| 149 | Granulocytopenia (HP:0001913) | 1.76879876 |
| 150 | Oral leukoplakia (HP:0002745) | 1.76016858 |
| 151 | Urticaria (HP:0001025) | 1.74566209 |
| 152 | Autoimmune hemolytic anemia (HP:0001890) | 1.74150248 |
| 153 | Axonal loss (HP:0003447) | 1.74080337 |
| 154 | Abnormality of magnesium homeostasis (HP:0004921) | 1.73671412 |
| 155 | Orchitis (HP:0100796) | 1.72881793 |
| 156 | Increased serum ferritin (HP:0003281) | 1.72580308 |
| 157 | Nuclear cataract (HP:0100018) | 1.71380626 |
| 158 | Increased IgE level (HP:0003212) | 1.71211272 |
| 159 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.70509770 |
| 160 | Molar tooth sign on MRI (HP:0002419) | 1.68654336 |
| 161 | Abnormality of midbrain morphology (HP:0002418) | 1.68654336 |
| 162 | Tubulointerstitial nephritis (HP:0001970) | 1.68003335 |
| 163 | Cone-rod dystrophy (HP:0000548) | 1.66058095 |
| 164 | Spontaneous hematomas (HP:0007420) | 1.66017091 |
| 165 | Aortic regurgitation (HP:0001659) | 1.64573627 |
| 166 | Dicarboxylic aciduria (HP:0003215) | 1.63231199 |
| 167 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.63231199 |
| 168 | Metaphyseal cupping (HP:0003021) | 1.63029535 |
| 169 | Optic neuritis (HP:0100653) | 1.62744480 |
| 170 | Retrobulbar optic neuritis (HP:0100654) | 1.62744480 |
| 171 | Aplasia/hypoplasia of the femur (HP:0005613) | 1.60546733 |
| 172 | Cervical subluxation (HP:0003308) | 1.60166245 |
| 173 | Microcytic anemia (HP:0001935) | 1.60074941 |
| 174 | Myocardial infarction (HP:0001658) | 1.58418692 |
| 175 | Cortical visual impairment (HP:0100704) | 1.58248830 |
| 176 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.57288726 |
| 177 | Diaphragmatic weakness (HP:0009113) | 1.57060157 |
| 178 | Aplasia/Hypoplasia involving the pelvis (HP:0009103) | 1.56353386 |
| 179 | Gingival bleeding (HP:0000225) | 1.55429615 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 3.69190622 |
| 2 | STK16 | 3.63402360 |
| 3 | MST4 | 2.89354706 |
| 4 | TLK1 | 2.75720839 |
| 5 | IRAK4 | 2.59525371 |
| 6 | ICK | 2.57232287 |
| 7 | PRKCH | 2.45613444 |
| 8 | RIPK4 | 2.42541320 |
| 9 | IRAK3 | 2.39395215 |
| 10 | PIM2 | 2.38005620 |
| 11 | TXK | 2.34399519 |
| 12 | MAP4K1 | 2.23892887 |
| 13 | PBK | 2.22693487 |
| 14 | BLK | 2.06690692 |
| 15 | TYRO3 | 2.05583630 |
| 16 | TEC | 2.04386105 |
| 17 | CSK | 2.00207975 |
| 18 | PIK3CG | 1.96868573 |
| 19 | VRK1 | 1.85022704 |
| 20 | DDR2 | 1.81946876 |
| 21 | TESK2 | 1.81373753 |
| 22 | EIF2AK1 | 1.80739024 |
| 23 | EPHB2 | 1.73667667 |
| 24 | EPHB1 | 1.73556167 |
| 25 | MAP3K14 | 1.67188409 |
| 26 | IKBKE | 1.63246433 |
| 27 | ERN1 | 1.61468534 |
| 28 | NME1 | 1.60523374 |
| 29 | MAP3K1 | 1.59235234 |
| 30 | PRKD2 | 1.57524423 |
| 31 | EPHA2 | 1.46390195 |
| 32 | CDC42BPA | 1.44977810 |
| 33 | STK39 | 1.44875461 |
| 34 | BTK | 1.43859337 |
| 35 | MAP3K2 | 1.42883647 |
| 36 | TBK1 | 1.39561334 |
| 37 | CDK19 | 1.39428994 |
| 38 | IKBKB | 1.37867032 |
| 39 | ZAP70 | 1.35181016 |
| 40 | ADRBK2 | 1.34942233 |
| 41 | MAP2K2 | 1.33905459 |
| 42 | TIE1 | 1.33153933 |
| 43 | IRAK1 | 1.30098940 |
| 44 | TAOK3 | 1.29322363 |
| 45 | MYLK | 1.27509121 |
| 46 | FGR | 1.26896362 |
| 47 | MAPKAPK5 | 1.26791587 |
| 48 | BMPR1B | 1.23954461 |
| 49 | EIF2AK3 | 1.23425006 |
| 50 | KDR | 1.22048173 |
| 51 | TYK2 | 1.20982189 |
| 52 | BRSK1 | 1.17038650 |
| 53 | PTK2B | 1.16237826 |
| 54 | TAOK1 | 1.15637970 |
| 55 | GRK7 | 1.14834905 |
| 56 | GRK6 | 1.14722868 |
| 57 | SRPK1 | 1.10731248 |
| 58 | KIT | 1.07086288 |
| 59 | CLK1 | 1.03517732 |
| 60 | SYK | 1.02766744 |
| 61 | ADRBK1 | 0.99204796 |
| 62 | EIF2AK2 | 0.98935266 |
| 63 | EPHA3 | 0.98838827 |
| 64 | YES1 | 0.98113449 |
| 65 | BCKDK | 0.97799676 |
| 66 | LYN | 0.97173219 |
| 67 | MAP3K12 | 0.94202279 |
| 68 | ZAK | 0.93948920 |
| 69 | MATK | 0.93677752 |
| 70 | BUB1 | 0.93281131 |
| 71 | LCK | 0.92362044 |
| 72 | NLK | 0.90957350 |
| 73 | TAOK2 | 0.89111783 |
| 74 | BCR | 0.89021006 |
| 75 | JAK3 | 0.88872177 |
| 76 | OXSR1 | 0.88671235 |
| 77 | RPS6KA5 | 0.87004514 |
| 78 | MAPK15 | 0.86067283 |
| 79 | MARK2 | 0.85460858 |
| 80 | RPS6KA2 | 0.85262192 |
| 81 | FES | 0.85248355 |
| 82 | STK38 | 0.84964167 |
| 83 | CDK8 | 0.81799447 |
| 84 | ITK | 0.81171742 |
| 85 | LIMK1 | 0.78014344 |
| 86 | PRKCD | 0.77330777 |
| 87 | MAP2K4 | 0.76620699 |
| 88 | TESK1 | 0.76255745 |
| 89 | RPS6KA4 | 0.74015433 |
| 90 | RPS6KC1 | 0.72199253 |
| 91 | RPS6KL1 | 0.72199253 |
| 92 | MAP3K6 | 0.71519297 |
| 93 | GRK1 | 0.71050531 |
| 94 | PIK3CA | 0.71016135 |
| 95 | DYRK2 | 0.69959236 |
| 96 | IRAK2 | 0.68361018 |
| 97 | RPS6KA6 | 0.66504758 |
| 98 | DYRK1B | 0.65739975 |
| 99 | MAP2K7 | 0.64851693 |
| 100 | MKNK1 | 0.62802379 |
| 101 | MAP3K8 | 0.62340121 |
| 102 | NEK6 | 0.61991686 |
| 103 | KSR1 | 0.61557465 |
| 104 | ARAF | 0.61371428 |
| 105 | PASK | 0.60550700 |
| 106 | MAP3K5 | 0.60308487 |
| 107 | TNK2 | 0.59468211 |
| 108 | BMPR2 | 0.58540090 |
| 109 | TNIK | 0.57667401 |
| 110 | ILK | 0.56677865 |
| 111 | ACVR1B | 0.55307929 |
| 112 | JAK2 | 0.54875468 |
| 113 | STK4 | 0.54334251 |
| 114 | TRPM7 | 0.53637964 |
| 115 | MAP3K7 | 0.53429880 |
| 116 | RPS6KB2 | 0.53324248 |
| 117 | BRAF | 0.53172945 |
| 118 | PIM1 | 0.52881206 |
| 119 | CASK | 0.52515997 |
| 120 | WNK4 | 0.52504852 |
| 121 | GSK3A | 0.52487879 |
| 122 | STK10 | 0.52057298 |
| 123 | MAP2K3 | 0.50486354 |
| 124 | PRKD1 | 0.50224236 |
| 125 | LRRK2 | 0.49848511 |
| 126 | KSR2 | 0.49644975 |
| 127 | MAPKAPK2 | 0.49586461 |
| 128 | NTRK3 | 0.49266993 |
| 129 | PRKCQ | 0.47100867 |
| 130 | INSRR | 0.47045367 |
| 131 | NEK9 | 0.45983284 |
| 132 | AURKB | 0.45902362 |
| 133 | CDK3 | 0.45781205 |
| 134 | WNK1 | 0.45048619 |
| 135 | MAP4K2 | 0.44925990 |
| 136 | MAP3K11 | 0.44836704 |
| 137 | CSNK2A1 | 0.44633634 |
| 138 | CSNK1G3 | 0.44139029 |
| 139 | SIK1 | 0.44081711 |
| 140 | MAPK4 | 0.43386443 |
| 141 | DAPK3 | 0.42569047 |
| 142 | PKN1 | 0.41499238 |
| 143 | ABL1 | 0.41318317 |
| 144 | RPS6KA1 | 0.41210992 |
| 145 | MAPK7 | 0.40746656 |
| 146 | TRIB3 | 0.40567218 |
| 147 | HCK | 0.40440844 |
| 148 | SRC | 0.39886765 |
| 149 | TGFBR2 | 0.38459724 |
| 150 | HIPK2 | 0.38281164 |
| 151 | MAP3K3 | 0.38032700 |
| 152 | CSF1R | 0.38006299 |
| 153 | CDK9 | 0.37867908 |
| 154 | CAMKK2 | 0.37757789 |
| 155 | MKNK2 | 0.37505980 |
| 156 | DYRK3 | 0.37468358 |
| 157 | FLT3 | 0.36982248 |
| 158 | ABL2 | 0.35283799 |
| 159 | AURKA | 0.35053298 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 5.20031703 |
| 2 | Protein export_Homo sapiens_hsa03060 | 3.58551781 |
| 3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.19561181 |
| 4 | Proteasome_Homo sapiens_hsa03050 | 2.97196549 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.78004978 |
| 6 | Parkinsons disease_Homo sapiens_hsa05012 | 2.77120348 |
| 7 | RNA polymerase_Homo sapiens_hsa03020 | 2.64182397 |
| 8 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.35800630 |
| 9 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.33747320 |
| 10 | DNA replication_Homo sapiens_hsa03030 | 2.21103056 |
| 11 | Viral myocarditis_Homo sapiens_hsa05416 | 2.02728373 |
| 12 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.02004926 |
| 13 | Alzheimers disease_Homo sapiens_hsa05010 | 1.98849444 |
| 14 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.95328286 |
| 15 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.95054749 |
| 16 | Huntingtons disease_Homo sapiens_hsa05016 | 1.84655997 |
| 17 | Mismatch repair_Homo sapiens_hsa03430 | 1.84411788 |
| 18 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.83390422 |
| 19 | Homologous recombination_Homo sapiens_hsa03440 | 1.79736409 |
| 20 | Other glycan degradation_Homo sapiens_hsa00511 | 1.73714067 |
| 21 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.69756026 |
| 22 | Allograft rejection_Homo sapiens_hsa05330 | 1.58989400 |
| 23 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.56971059 |
| 24 | Base excision repair_Homo sapiens_hsa03410 | 1.54128874 |
| 25 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.50695920 |
| 26 | Spliceosome_Homo sapiens_hsa03040 | 1.47386507 |
| 27 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.43478660 |
| 28 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.39700943 |
| 29 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.38894625 |
| 30 | Sulfur relay system_Homo sapiens_hsa04122 | 1.37962198 |
| 31 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.33601835 |
| 32 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.32652258 |
| 33 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.29248696 |
| 34 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.26349691 |
| 35 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.25482489 |
| 36 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.24231148 |
| 37 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.23990597 |
| 38 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.22005292 |
| 39 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.20009831 |
| 40 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.19944421 |
| 41 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.17688531 |
| 42 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.17321156 |
| 43 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.15918904 |
| 44 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.13420299 |
| 45 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.13346214 |
| 46 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.11910788 |
| 47 | Leishmaniasis_Homo sapiens_hsa05140 | 1.11756172 |
| 48 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.07051263 |
| 49 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.06962392 |
| 50 | Amoebiasis_Homo sapiens_hsa05146 | 1.04512673 |
| 51 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.00276031 |
| 52 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.00219878 |
| 53 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.00167374 |
| 54 | Measles_Homo sapiens_hsa05162 | 0.99768632 |
| 55 | Purine metabolism_Homo sapiens_hsa00230 | 0.99115256 |
| 56 | Asthma_Homo sapiens_hsa05310 | 0.98281202 |
| 57 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.97628672 |
| 58 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.96124995 |
| 59 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.92382434 |
| 60 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.90862758 |
| 61 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.90260423 |
| 62 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.88889498 |
| 63 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.87997605 |
| 64 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.87992372 |
| 65 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.87395897 |
| 66 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.85884979 |
| 67 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.85588480 |
| 68 | Bladder cancer_Homo sapiens_hsa05219 | 0.85447112 |
| 69 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.85126725 |
| 70 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.84697853 |
| 71 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.84660353 |
| 72 | Pertussis_Homo sapiens_hsa05133 | 0.84486726 |
| 73 | Basal transcription factors_Homo sapiens_hsa03022 | 0.84424156 |
| 74 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.84098008 |
| 75 | Galactose metabolism_Homo sapiens_hsa00052 | 0.83350079 |
| 76 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.82540386 |
| 77 | RNA degradation_Homo sapiens_hsa03018 | 0.80421579 |
| 78 | Malaria_Homo sapiens_hsa05144 | 0.80284508 |
| 79 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.79419320 |
| 80 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.75873365 |
| 81 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.75110813 |
| 82 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.74820685 |
| 83 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.74044588 |
| 84 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.71906216 |
| 85 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.71411322 |
| 86 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.70153477 |
| 87 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.66922281 |
| 88 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.66324913 |
| 89 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.65022107 |
| 90 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.64997387 |
| 91 | Legionellosis_Homo sapiens_hsa05134 | 0.63485769 |
| 92 | Endocytosis_Homo sapiens_hsa04144 | 0.61845536 |
| 93 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.60722036 |
| 94 | Apoptosis_Homo sapiens_hsa04210 | 0.60690851 |
| 95 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.60684375 |
| 96 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.59257438 |
| 97 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.59000858 |
| 98 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.57151524 |
| 99 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.56613595 |
| 100 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.56324256 |
| 101 | Lysosome_Homo sapiens_hsa04142 | 0.54601861 |
| 102 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.54342751 |
| 103 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.54241970 |
| 104 | Metabolic pathways_Homo sapiens_hsa01100 | 0.53284627 |
| 105 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.51721287 |
| 106 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.51674628 |
| 107 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.51573682 |
| 108 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.51383093 |
| 109 | Influenza A_Homo sapiens_hsa05164 | 0.50814997 |
| 110 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.50519071 |
| 111 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.48324069 |
| 112 | Shigellosis_Homo sapiens_hsa05131 | 0.48277025 |
| 113 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.47590321 |
| 114 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.47534288 |
| 115 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.47152045 |
| 116 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.46026908 |
| 117 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.44973594 |
| 118 | Hepatitis C_Homo sapiens_hsa05160 | 0.41141733 |
| 119 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.40262565 |
| 120 | Tuberculosis_Homo sapiens_hsa05152 | 0.39078655 |
| 121 | Phagosome_Homo sapiens_hsa04145 | 0.38908295 |
| 122 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.38718620 |
| 123 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.38718114 |
| 124 | Hepatitis B_Homo sapiens_hsa05161 | 0.38647039 |
| 125 | Salmonella infection_Homo sapiens_hsa05132 | 0.38359251 |
| 126 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.37633998 |
| 127 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.35684648 |
| 128 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.34473897 |
| 129 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.34363753 |
| 130 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.33637597 |
| 131 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.33609049 |
| 132 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.31783845 |
| 133 | Peroxisome_Homo sapiens_hsa04146 | 0.31696520 |
| 134 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.31614637 |
| 135 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.30949402 |
| 136 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.30441663 |
| 137 | RNA transport_Homo sapiens_hsa03013 | 0.29357318 |
| 138 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.28914187 |
| 139 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.28772430 |
| 140 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.28203006 |
| 141 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.27931670 |
| 142 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.27011850 |

